Literature DB >> 12409691

Primary skeletal neoplasms: osteosarcoma and ewing sarcoma.

Fredric A Hoffer1.   

Abstract

The care for children and adolescents with malignant bone tumors such as osteosarcoma and Ewing sarcoma will be improved by the magnetic resonance imager that can recognize the tumor early in its course and can stage it correctly for proper chemotherapy and local control. This can be accomplished by attention to the proper magnetic resonance imaging technique, recognition of the magnetic resonance appearance, and knowledge of the prognostic factors at diagnosis. Determination of response on follow-up static and dynamic contrast-enhanced magnetic resonance imaging and knowledge of optimal methods to determine recurrent tumor will improve the outcome for these children.

Entities:  

Mesh:

Year:  2002        PMID: 12409691     DOI: 10.1097/00002142-200208000-00004

Source DB:  PubMed          Journal:  Top Magn Reson Imaging        ISSN: 0899-3459


  4 in total

Review 1.  Characterization of pediatric skeletal tumors and tumor-like conditions: specific cross-sectional imaging signs.

Authors:  Laura M Fayad; David A Bluemke; Kristin L Weber; Elliot K Fishman
Journal:  Skeletal Radiol       Date:  2006-03-15       Impact factor: 2.199

2.  Ewing sarcoma versus osteomyelitis: differential diagnosis with magnetic resonance imaging.

Authors:  B Henninger; B Glodny; A Rudisch; T Trieb; A Loizides; D Putzer; W Judmaier; M F Schocke
Journal:  Skeletal Radiol       Date:  2013-05-19       Impact factor: 2.199

Review 3.  Malignant bone tumors and limb-salvage surgery in children.

Authors:  James S Meyer; William Mackenzie
Journal:  Pediatr Radiol       Date:  2004-06-19

4.  Multidisciplinary approach to diagnosis and management of osteosarcoma - a review of the St Vincent's Hospital experience.

Authors:  Judith Zhi-Yie Tan; Stephen M Schlicht; Gerard J Powell; David Thomas; John L Slavin; Peter J Smith; Peter F M Choong
Journal:  Int Semin Surg Oncol       Date:  2006-11-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.